Friday, January 4, 2013
The Westborough firm shares owners with the Framingham company tied to the meningitis outbreak.
State health officials have extended the closing of Ameridose for six weeks, the Boston Globe reports. The Globe reports the state Department of Public Health said in a statement that the Westborough drug company will continue undergoing a joint state and federal investigation regarding “unsanitary conditions and questionable sterility practices at the facility." Ameridose shares owners with the New England Compounding Center, a specialty pharmacy in Framingham linked to the national deadly meningitis outbreak. On Oct. 10, the Massachusetts Board of Registration in Pharmacy reached an agreement with Ameridose to close so that investigators could determine if its products had also been contaminated. In November, federal Food and Drug …
Monday, November 12, 2012
Ameridose responded to the findings in a statement.
Federal Food and Drug Administration inspectors saw insects and a bird while inspecting Ameridose, a Westborough facility that shares owners with the Framingham specialty phramcy connected to a national meningitis outbreak, WCVB reported today. The insects were seen "within 10 feet of a supposedly sterile area where drugs are manufactured," WCVB reported. "In another case, inspectors reported a bird flying into a room where drugs are stored." Ameridose responded to the findings in a statement. “We have received the FDA’s written observations included in their Form 483 that is based on a comprehensive 30-day review of our facilities and our processes, conducted by more than 20 inspectors representing both state and federal agencies," the …
Thursday, November 8, 2012
The Westborough-based company has been closed while cooperating with an FDA investigation.
Ameridose, the Westborough facility that shares owners with the Framingham company connected to a national meningitis outbreak, handed out hundreds of layoff notices today. The Boston Globe is reporting that the layoffs, which will start Friday, affect 650 workers at Ameridose and 140 at its affiliated marketing company, Medical Sales Management. Ameridose has been closed, and will remain closed until Nov. 19, to let the FDA inspect the facility. Ameridose has not been directly implicated in the meningitis outbreak. Its sister company, the Framingham-based New England Compounding Center, had its license revoked and is blamed for producing steroid injections that caused 31 deaths and 424 cases of fungal meningitis and joint infections. …
Friday, November 2, 2012
The pharmacy says the move expands its cooperation with the FDA.
UPDATE, 3:30 p.m. Nov. 2: Ameridose, the Westborough facility that shares owners with the Framingham company connected to a national meningitis outbreak, will be closed until at least Nov. 19. The temporary closure of Ameridose LLC, by mutual agreement with state regulators, was extended to give investigators more time to inspect the facility, the Boston Globe reported. ORIGINAL STORY: The Boston Globe reports that Ameridose voluntarily has recalled all of its drugs following an ongoing FDA inspection of the Westborough facility. In a press release today, Ameridose officials said the recall "represents an expansion of our cooperation with the U.S. Food and Drug Administration and the Massachusetts Board of Registration in Pharmacy." "…
42.27449
-71.55742
Ameridose
201 Flanders Rd, Westborough, MA
/articles/ameridose-voluntarily-recalls-products
1910646
/locations/8096162
Saturday, October 20, 2012
Since the first death, lawsuits, in 6 states, have been filed against Framingham-based New England Compounding Center.
The Centers for Disease Control and Prevention increased it numbers in the deadly meningitis outbreak to 23 dead. The new deaths reported in Tennessee and North Carolina. The CDC said the outbreak, linked to tainted steroids produced at New England Compounding Center in Framingham, has reached 16 states with 284 cases, including 23 deaths. New England Compounding Center (NECC) recalled steroids tained with a fungus, in late September. Over Columbus Day weekend, NECC recalled all 1,200 of its products. For a list of all the products, click here. Last week, federal officials raided the Waverly Road specialty pharmacy. Since the first death, lawsuits, in 6 states, have been filed against NECC. NECC has suspended operations, and surrendered …
42.273356
-71.426773
New England Compounding Center
697 Waverly St, Framingham, MA
/articles/cdc-23-dead-284-infected-in-national-menigitis-outbreak
798932
/locations/8042980
Friday, October 19, 2012
The owners of Ameridose, also own New England Compounding Center, a specialty pharmacy in Framingham linked to a deadly meningitis outbreak.
The owners of a Westborough pharmacy, who also own a Framingham specialty pharmacy linked to the national deadly meningitis outbreak, have agreed to close until Nov. 5, so it can be inspected. The meningitis outbreak, linked to New England Compounding Center in Framingham, has killed 21 people and infected more than 250 others across America. Lawsuits have been filed against New England Compounding Center in Framingham in 6 states. Ameridose, which at one point was located in Framingham, but now is located in Westborough agreed to the closure extension with state health officials Friday. The Massachusetts Board of Registration in Pharmacy told Ameridose it “finds it necessary to extend the agreement to conduct a comprehensive …
Wednesday, October 10, 2012
Ameridose, which has the same owners as the Framingham company linked to a meningitis outbreak, has agreed to temporarily shut down for inspection.
UPDATED, 7:05 p.m.: This story has been updated with a statement from Ameridose. A Westborough firm that provides sterile medication in prefilled oral syringes to thousands of hospitals, has agreed to temporarily close for inspection by state and federal regulators. The company has the same owners as the New England Compounding Center in Framingham, which produced a steroid linked to a meningitis outbreak. Both firms are run by Barry Cadden and Greg Conigliaro, the Associated Press is reporting. Ameridose provided the following statement in an email Wednesday evening: "Ameridose today agreed to voluntarily and temporarily cease certain operations, including production and shipping of all products, while the Massachusetts Department of …
Barry Ponzio
11:35 pm on Monday, January 7, 2013
How could these guys operate with such utter disdain for patients and patient safety. I guess greed is a deadly sin. more ›